Sebela Ireland Ltd Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for SEBELA IRELAND LTD, and what generic alternatives to SEBELA IRELAND LTD drugs are available?
SEBELA IRELAND LTD has seventeen approved drugs.
There are eleven US patents protecting SEBELA IRELAND LTD drugs.
There are eighty-three patent family members on SEBELA IRELAND LTD drugs in thirty-six countries and two supplementary protection certificates in two countries.
Summary for Sebela Ireland Ltd
| International Patents: | 83 |
| US Patents: | 11 |
| Tradenames: | 12 |
| Ingredients: | 10 |
| NDAs: | 17 |
Drugs and US Patents for Sebela Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | 9,161,914 | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sebela Ireland Ltd | ONMEL | itraconazole | TABLET;ORAL | 022484-001 | Apr 29, 2010 | DISCN | Yes | No | 8,486,456 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sebela Ireland Ltd | BRISDELLE | paroxetine mesylate | CAPSULE;ORAL | 204516-001 | Jun 28, 2013 | AB | RX | Yes | Yes | 8,658,663 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | 10,695,303 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| Sebela Ireland Ltd | PRAMOSONE | hydrocortisone acetate; pramoxine hydrochloride | CREAM;TOPICAL | 085368-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-001 | Feb 29, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sebela Ireland Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-001 | Jul 3, 2003 | 6,703,408 | ⤷ Try a Trial |
| Sebela Ireland Ltd | PEXEVA | paroxetine mesylate | TABLET;ORAL | 021299-003 | Jul 3, 2003 | 6,703,408 | ⤷ Try a Trial |
| Sebela Ireland Ltd | ONMEL | itraconazole | TABLET;ORAL | 022484-001 | Apr 29, 2010 | 8,591,948 | ⤷ Try a Trial |
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 019356-001 | Jun 18, 1990 | 4,282,251 | ⤷ Try a Trial |
| Sebela Ireland Ltd | BRISDELLE | paroxetine mesylate | CAPSULE;ORAL | 204516-001 | Jun 28, 2013 | 5,874,447 | ⤷ Try a Trial |
| Sebela Ireland Ltd | NAFTIN | naftifine hydrochloride | CREAM;TOPICAL | 019599-001 | Feb 29, 1988 | 4,282,251 | ⤷ Try a Trial |
| Sebela Ireland Ltd | LOTRONEX | alosetron hydrochloride | TABLET;ORAL | 021107-001 | Feb 9, 2000 | 6,284,770 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SEBELA IRELAND LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | 2010-12-02 |
| ➤ Subscribe | Capsules | 7.5 mg | ➤ Subscribe | 2014-04-07 |
International Patents for Sebela Ireland Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Greece | 3035784 | ⤷ Try a Trial |
| Slovenia | 0994872 | ⤷ Try a Trial |
| Croatia | P20181925 | ⤷ Try a Trial |
| Slovakia | 161999 | ⤷ Try a Trial |
| South Korea | 20010013615 | ⤷ Try a Trial |
| Norway | 343176 | ⤷ Try a Trial |
| European Patent Office | 1912625 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sebela Ireland Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
